CME Group Inc. (NASDAQ:CME) Shares Sold by FNY Investment Advisers LLC

FNY Investment Advisers LLC lowered its holdings in CME Group Inc. (NASDAQ:CME - Free Report) by 37.6% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 10,300 shares of the financial services provider's stock after selling 6,200 shares during the period. CME Group makes up 1.7% of FNY Investment Advisers LLC's holdings, making the stock its 9th biggest holding. FNY Investment Advisers LLC's holdings in CME Group were worth $2,732,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in the business. New Age Alpha Advisors LLC grew its stake in CME Group by 50.0% during the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after purchasing an additional 43 shares in the last quarter. Knuff & Co LLC purchased a new position in CME Group in the 4th quarter valued at $33,000. Banque Transatlantique SA acquired a new stake in CME Group in the 4th quarter valued at about $35,000. Whipplewood Advisors LLC acquired a new stake in CME Group in the 4th quarter valued at about $37,000. Finally, United Community Bank acquired a new position in CME Group during the fourth quarter worth about $37,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, Director Larry G. Gerdes sold 2,000 shares of the business's stock in a transaction dated Thursday, April 24th. The stock was sold at an average price of $264.10, for a total value of $528,200.00. Following the transaction, the director now owns 38,651 shares in the company, valued at approximately $10,207,729.10. The trade was a 4.92% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Charles P. Carey sold 500 shares of the stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $265.35, for a total value of $132,675.00. Following the completion of the transaction, the director now directly owns 4,900 shares of the company's stock, valued at $1,300,215. This represents a 9.26% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 13,400 shares of company stock valued at $3,680,610. Corporate insiders own 0.30% of the company's stock.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the company. UBS Group lifted their price objective on CME Group from $290.00 to $305.00 and gave the stock a "buy" rating in a research report on Friday, April 25th. Erste Group Bank cut CME Group from a "strong-buy" rating to a "hold" rating in a report on Saturday, May 24th. Raymond James raised CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price objective on the stock in a research note on Monday, March 10th. Oppenheimer boosted their target price on shares of CME Group from $282.00 to $300.00 and gave the company an "outperform" rating in a research note on Wednesday, June 4th. Finally, JPMorgan Chase & Co. reduced their target price on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating on the stock in a report on Thursday, April 24th. Three analysts have rated the stock with a sell rating, eight have assigned a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $258.20.

CME Group Trading Down 0.7%

CME Group stock traded down $1.99 during midday trading on Monday, reaching $267.51. The stock had a trading volume of 3,208,152 shares, compared to its average volume of 2,204,760. The stock's 50-day simple moving average is $272.73 and its 200 day simple moving average is $254.51. The stock has a market capitalization of $96.40 billion, a PE ratio of 27.66, a price-to-earnings-growth ratio of 6.76 and a beta of 0.45. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $290.79. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, topping analysts' consensus estimates of $2.61 by $0.19. CME Group had a return on equity of 13.62% and a net margin of 57.52%. The company had revenue of $1.64 billion for the quarter, compared to analysts' expectations of $1.56 billion. During the same quarter in the previous year, the firm posted $2.50 earnings per share. The firm's quarterly revenue was up 10.4% on a year-over-year basis. Analysts expect that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Monday, June 9th will be given a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.87%. The ex-dividend date of this dividend is Monday, June 9th. CME Group's dividend payout ratio (DPR) is presently 50.30%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.